Chemoprevention and therapy of mouse mammary carcinomas with doxorubicin encapsulated in sterically stabilized liposomes.


BACKGROUND The objective of this study was to determine the ability of doxorubicin, encapsulated in sterically stabilized liposomes (Doxil [Liposome Technology, Inc., Menlo Park, CA]), to inhibit the spontaneous development of mammary carcinomas in mice. METHODS Monthly prophylactic intravenous injections of 6 mg/kg doses of Doxil were started when… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.